Health Professional Radio - Podcast

Returning guest, Dr. Steve Tilles, Senior Director of Medical Affairs at Aimmune Therapeutics, the first company to gain FDA approval of a peanut allergy treatment, PALFORZIA™, discusses his experience as an allergist, where the allergy immunology market is headed over the next year and provides real-world insight into practices reopening in light of COVID-19.